GlassScriptPhysician profile
Channing J Hampton
NPI 1164714416
$9,027.31
in general payments reported to CMS, 2019-2025
43 companies · $914 in 2025
The $914 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,764 · 2020: $1,228 · 2021: $1,910 · 2022: $977 · 2023: $994 · 2024: $1,240 · 2025: $914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,147.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,001.53 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $1,667.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,116.93 | 2019-2025 | |
| Amgen INC. | $434.79 | 2019-2025 | Evenity, Repatha, Otezla |
| Pfizer INC. | $375.36 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $353.63 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $340.77 | 2019-2021 | |
| Astellas Pharma US INC | $297.51 | 2019-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $262.19 | 2019-2024 | Farxiga |
| Allergan, INC. | $257.46 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $188.81 | 2019-2021 | |
| Abbott Laboratories | $169.86 | 2020-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $145.87 | 2019-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $132.97 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $132.39 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Channing Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.